Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.24 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 2 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 1751
Sealed predictions
- C4BPA in dopamine neurons, braak+0.64 (p 0.061) → -0.29 (p 0.457)receipt 1757
Swarm cases
receipt 1757: C4BPA in dopamine neurons, braak
- power
- full sample +0.37 (p 0.131, n 18), 95% CI -0.12 to +0.71. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.35 (p 0.160, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.32 (p 0.198, n 18). could be the mix.
- skeptic
- leave-one-out range +0.28 to +0.51, sign flips 0; without severely affected donors +0.37 (p 0.131, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C4BPA in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts